Paper42439643
Macrophage Metabolic Reprogramming in Rheumatoid Arthritis: Pathogenic Mechanisms and Therapeutic Implications.
Chen L and 7 others. Cells, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Macrophage Metabolic Reprogramming in Rheumatoid Arthritis: Pathogenic Mechanisms and Therapeutic Implications. Papers, record 42439643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42439643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Macrophage Metabolic Reprogramming in Rheumatoid Arthritis: Pathogenic Mechanisms and Therapeutic Implications.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Macrophages | Major topic |
| Metabolic Reprogramming | Major topic |
| Humans | |
| Animals | |
| Synovial Membrane | |
| Inflammation |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82405235 | National Natural Science Foundation of China | PubMed | ||
| 82274506 | National Natural Science Foundation of China | PubMed | ||
| KH[2023]3-23YS001 | Chinese Academy of Engineering Academician Liang Liu's Workstation Project | PubMed | ||
| XJF[2022]57 | World First-class Discipline Incubation Project | PubMed | ||
| 2025XJZB001 | Excellent Youth Program of Hunan University of Chinese Medicine | PubMed | ||
| 2022M721128 | China Postdoctoral Science Foundation | PubMed | ||
| 2024T170267 | China Postdoctoral Science Foundation | PubMed |
Source PubMed
References190
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40500265 | Inflammatory macrophage-derived itaconate inhibits DNA demethylase TET2 to prevent excessive osteoclast activation in rheumatoid arthritis. | Bone Res | 2025 | https://conductscience.org/library/papers/40500265 | PubMed |
| 2 | 38937071 | Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis. | Ann Rheum Dis | 2024 | https://conductscience.org/library/papers/38937071 | PubMed |
| 3 | 36398893 | Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations. | Rheumatology (Oxford) | 2023 | https://conductscience.org/library/papers/36398893 | PubMed |
| 4 | 34952630 | CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients. | Arthritis Res Ther | 2021 | https://conductscience.org/library/papers/34952630 | PubMed |
| 5 | 41279898 | The ontogeny of myeloid-stromal synovial tissue niches in rheumatoid arthritis. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279898 | PubMed |
| 6 | 22944456 | Reversible differentiation of pro- and anti-inflammatory macrophages. | Mol Immunol | 2013 | https://conductscience.org/library/papers/22944456 | PubMed |
| 7 | 18799722 | CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. | Blood | 2008 | https://conductscience.org/library/papers/18799722 | PubMed |
| 8 | 32719038 | Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study. | Ann Rheum Dis | 2021 | https://conductscience.org/library/papers/32719038 | PubMed |
| 9 | 38644410 | Unveiling the link between lactate metabolism and rheumatoid arthritis through integration of bioinformatics and machine learning. | Sci Rep | 2024 | https://conductscience.org/library/papers/38644410 | PubMed |
| 10 | 41391371 | Sanmiao pill ameliorates rheumatoid arthritis via PPARγ-mediated lipid accumulation in macrophage: A multi-omics and experimental validation. | Phytomedicine | 2026 | https://conductscience.org/library/papers/41391371 | PubMed |
| 11 | 38283352 | Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner. | Front Immunol | 2023 | https://conductscience.org/library/papers/38283352 | PubMed |
| 12 | 40230232 | Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries. | Arthritis Rheumatol | 2025 | https://conductscience.org/library/papers/40230232 | PubMed |
| 13 | 32601335 | Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. | Nat Med | 2020 | https://conductscience.org/library/papers/32601335 | PubMed |
| 14 | 32738596 | Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/ HIF-1α pathway. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/32738596 | PubMed |
| 15 | 35785731 | Peptidyl arginine deiminase expression and macrophage polarization following stimulation with citrullinated and malondialdehyde-acetaldehyde modified fibrinogen. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/35785731 | PubMed |
| 16 | 22889211 | Metabolism and autophagy in the immune system: immunometabolism comes of age. | Immunol Rev | 2012 | https://conductscience.org/library/papers/22889211 | PubMed |
| 17 | 38964754 | Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis. | Ann Rheum Dis | 2024 | https://conductscience.org/library/papers/38964754 | PubMed |
| 18 | 37746665 | Arachidonic acid metabolism in health and disease. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37746665 | PubMed |
| 19 | 31061532 | Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. | Nat Immunol | 2019 | https://conductscience.org/library/papers/31061532 | PubMed |
| 20 | 30990796 | Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis. | J Clin Invest | 2019 | https://conductscience.org/library/papers/30990796 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42827859 | Immunometabolism and rheumatic disease-advancing targeted therapies. | EULAR Rheumatol Open | 2026 | https://conductscience.org/library/papers/42827859 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42439643
GET https://conductscience.org/api/papers/v1/42439643/references?page=2